$SRNE the play here isn’t the buyout offer. That’s not going to happen at these lowball offers. The near term play is the autologous CD38 CAR-T data an a partnership around their CD38 business unit. Data share tentatively due by end 1Q20. Anything else is noise.
  • 14
  • 11